- AdministratorJuly 6, 2020 at 8:12 am
There was a large randomized, open-label trial study done in the UK on low dose dexamethasone. This produced data that limited 28-day mortality compared to usual care. There was also many trials on Remdesivir that were promising. What are your thoughts on MOA of a steroid/antiviral and how it could be helping?
- MemberJuly 8, 2020 at 9:22 am
With the cytokine storm being a major problem in the virulent factors of Covid I found it pretty interesting they approach to blunt the immune response. You would think the immune response would be the best way to clear the infection, but it turns out it is the driver for destruction.
Does anyone know any other medication being used?
Hydroxychloroquine has been in and out of the spotlight. The MOA of this drug Is interesting on how it is projected to help fight the pandemic.
Log in to reply.